|
|
Volumn 15, Issue 1, 2010, Pages 19-20
|
|
Adding atypical antipsychotics to antidepressants increases response in treatment-resistant major depression but increases discontinuation as a result of adverse events
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDEPRESSANT AGENT;
ATYPICAL ANTIPSYCHOTIC AGENT;
DOPAMINE 2 RECEPTOR;
SEROTONIN 2A RECEPTOR;
SEROTONIN 2C RECEPTOR;
BODY WEIGHT;
CLINICAL TRIAL;
HUMAN;
HYPERPROLACTINEMIA;
MAJOR DEPRESSION;
MEDICAL DECISION MAKING;
MEDLINE;
METABOLIC SYNDROME X;
NOTE;
PSYCHOTHERAPY;
REMISSION;
SIDE EFFECT;
TARDIVE DYSKINESIA;
TREATMENT RESPONSE;
|
|
EID: 77249114717
PISSN: 13565524
EISSN: 14736810
Source Type: Journal
DOI: 10.1136/ebm1016 Document Type: Note |
|
Times cited : (6)
|
|
References (0)
|
